Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Risk Reduction clinical trials
2 of 14 indexed Risk Reduction trials are currently recruiting.
14 US clinical trials · 2 currently recruiting
Risk Reduction is the subject of 14 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Florida State University, running 2 of these trials.
The research picture
Risk Reduction has 14 registered US clinical trials, 2 of them open to new participants right now, about 14% of the total.
- 2
- recruiting participants now
- 14%
- of trials open to enrollment
- 1
- in Phase 3–4 (later-stage)
- 2
- top sponsor: Florida State University
Active & Recent Trials
14 total, page 1 of 1
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
San Raffaele University
NCT05732623
Blood Donor CVD 5000
University of Maryland, Baltimore
NCT03971669
Tennessee Youth Prepared for Success
Centerstone Research Institute
NCT06001892
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens
University of Kansas Medical Center
NCT04821141
Efficacy of Communication Modalities for Promoting Flu Shots
Geisinger Clinic
NCT05509270
Building Stronger Allies
Florida State University
NCT03571750
Prevention and Risk: Treatment With a New Emphasis on Relationships
Hunter College of City University of New York
NCT03396367
Acceptability, Feasibility, and Preliminary Impact of a Web-based, HIV Prevention Toolkit With Cisgender Male Couples in Lima, Peru
Florida International University
NCT05873855
Nature and Health: How Does Lifestyle and Environment Affect Health and Wellness
Stanford University
NCT06001697
Electronic Confirmed Versus Conventional Consenting Process: A Randomized Controlled Trial
The University of Texas Medical Branch, Galveston
NCT03510260
Salmonella Conjugates CVD 1000: Study of Responses to Vaccination With Trivalent Invasive Salmonella Disease Vaccine
University of Maryland, Baltimore
NCT03981952
Rural Chronic Disease Risk Reduction
Florida State University
NCT05611580
PrEP Point-of-Care Brief-Intervention for Adherence Among Young Men Who Have Sex With Men
University of California, San Francisco
NCT05353283
Monitoring Environmental Exposures and Behavioral Change
University of Utah
NCT05338242
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 4 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Risk Reduction Trial Landscape
14 indexed Risk Reduction studies · 2 recruiting (14%).
Phase mix: 1 late (III/IV) vs 2 early (I/II).
Top sponsor: Florida State University (2 trials), 9 others listed. 14 shown below, recruiting first.
How to read this condition's trial landscape
That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation, eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Risk Reduction?
PlainTrial tracks 14 US clinical trials for Risk Reduction, of which 2 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Risk Reduction?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.